vaccines and next-generation biologic therapeutics. Primrose’s unique and broad capabilities in nucleic acid engineering, molecular evolution and protein expression allow the company to create ...

Primrose Bio’s advanced technology for manufacturing nucleic acids and proteins makes it the partner of choice for pharma companies developing new vaccines, therapeutics and bio-based products.

The nanoadhesive is based on tetrahedral framework nucleic acids combined with functionalized polycationic recombinant proteins. This unique composition minimizes the risks of tissue necrosis and ...